Olpasiran trials of Cardiovascular Events lipoproteiN(a) reduction – Dose Finding Study (OCEAN(a)-DOSE) (NCT04270760)

Educational Partners and Supporters

AstraZeneca has provided a sponsorship grant towards this independent programme.